Dockets Entered On September 12, 2003

Table of Contents

Docket #

Title

1975N-0183H. 1          Health-Care Antiseptic Drug Products for OTC Human Use. 1

1994P-0036. 1             Req labeling of trans fatty acid & prohibit deceptive claims. 1

1997S-0162. 1             30-Day Structure Function Claim Notification Letters Dietary. 1

1998F-0196. 1             Safe use of Selenium Yeast in Animal Feeds. 1

2002N-0178. 1            Canned Tomatoes Deviating from Identity Standard. 1

2003N-0053. 1            Interstate Shellfish Dealers Certificate; Information Collect 1

2003N-0075. 1            Administrative Detention and Banned Med. Devices; Agency Infor 1

2003N-0198. 2            Agency Information Collection Activities: Proposed Collection; Comment Request; Medicated Feed Mill License  2

2003N-0369. 2            Solvay Pharmaceuticals, Inc.; Withdrawal of Approval of Two New Drug Applications; Determination That LUVOX (Fluvoxamine Maleate) 25-Milligram (mg), 50-mg, 100-mg, and 150-mg Tablets Was Not Withdrawn. 2

2003N-0376. 2            Medical Devices: Mammography Quality Standards Act of 1992 and Subsequent Mammography Quality Standards Reauthorization Act and Amendments; Inspection Fees  2

2003N-0384. 2            Hoffmann-La Roche, Inc.; Withdrawal of Approval of a New Drug Application. 2

2003V-0428. 2            Laser Light Show. 2

1975N-0183H

Health-Care Antiseptic Drug Products for OTC Human Use

C 86          Attachment

Cantox Health Sciences International

Vol #:

198

C 87        Attachments

Bode Chemie (Bode)

Vol #:

199

1994P-0036

Req labeling of trans fatty acid & prohibit deceptive claims

NAL 1

FDA

Vol #:

84

SS 1

Supporting Statement

Vol #:

84

1997S-0162

30-Day Structure Function Claim Notification Letters Dietary

LET 10883

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10884

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10885

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10886

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10887

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10888

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10889

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10890

Enzymatic Therapy Natural medicines

Vol #:

82

LET 10891

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10892

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10893

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10894

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10895

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10896

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10897

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10898

Nature's Life

Vol #:

82

LET 10899

Nature's Life

Vol #:

82

LET 10900

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10901

Herbalife International of America, Inc.

Vol #:

82

LET 10902

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10903

PhytoPharmica Natural Medicines

Vol #:

82

LET 10904

PhytoPharmica Natural Medicines

Vol #:

82

LET 10905

PhytoPharmica Natural Medicines

Vol #:

82

LET 10906

Enzymatic Therapy Naural Medicines

Vol #:

82

LET 10907

Enzymatic Therapy Natural Medicines

Vol #:

82

LET 10908

PhytoPharmica Natural Medicines

Vol #:

82

LET 10909

PhytoPharmica Natural Medicines

Vol #:

82

LET 10910

PhytoPharmica Natural Medicines

Vol #:

82

1998F-0196

Safe use of Selenium Yeast in Animal Feeds

NFR 3

FDA

Vol #:

1

2002N-0178

Canned Tomatoes Deviating from Identity Standard

NEC 1

FDA

Vol #:

1

2003N-0053

Interstate Shellfish Dealers Certificate; Information Collect

NAL 1

FDA

Vol #:

1

SS 1

Supporting Statement

Vol #:

1

2003N-0075

Administrative Detention and Banned Med. Devices; Agency Infor

NAL 1

FDA

Vol #:

1

SS 1

Supporting Statement

Vol #:

1

2003N-0198

Agency Information Collection Activities: Proposed Collection; Comment Request; Medicated Feed Mill License

NCR 1

FDA

Vol #:

1

2003N-0369

Solvay Pharmaceuticals, Inc.; Withdrawal of Approval of Two New Drug Applications; Determination That LUVOX (Fluvoxamine Maleate) 25-Milligram (mg), 50-mg, 100-mg, and 150-mg Tablets Was Not Withdrawn

NWL 1

FDA

Vol #:

1

2003N-0376

Medical Devices: Mammography Quality Standards Act of 1992 and Subsequent Mammography Quality Standards Reauthorization Act and Amendments; Inspection Fees

N 1

FDA

Vol #:

1

2003N-0384

Hoffmann-La Roche, Inc.; Withdrawal of Approval of a New Drug Application

NWL 1

FDA

Vol #:

1

2003V-0428

Laser Light Show

ACK 1

HFA-305 to Cunningham Products Resources

Vol #:

1

ACK 2

Number not used

Vol #:

1

ACK 3

Number not used

Vol #:

1

VAR 1

Cunningham Products Resources

Vol #:

1